Gastroenterology

At UEG Week 2024, researchers showed that TP53 mutations and chromosomal changes improve prediction of oesophageal adenocarcinoma in low-risk Barrett’s oesophagus.

A groundbreaking study presented at UEG Week 2024 has revealed distinct antibody responses in Crohn’s disease and ulcerative colitis apparent years before diagnosis.

Leading health experts at UEG Week 2024 are calling for the implementation of a national, quality-assured colorectal cancer screening programme for individuals aged 45–75.

A new guideline from The American Society of Colon and Rectal Surgeons highlights a personalised, multidisciplinary approach to managing chronic constipation

New research has highlighted a concerning rise in early-onset colorectal cancer cases, accompanied by more aggressive disease and inferior survival.  

A multicentre study shows endoscopic submucosal dissection is a safe, effective treatment for high-risk colorectal neoplasia in patients with inflammatory bowel disease.

Individuals with upper gastrointestinal mucosal damage may be at an increased risk of developing Parkinson’s disease later in life.

New research from DDW 2024 shows older adults with inflammatory bowel disease treated with advanced therapies may face a slightly increased risk of infection.